Onyx Pharm (ONXX) January Option Implied Volatility Elevated Phase 3
Tweet Send to a Friend
Onyx Pharma (Nasdaq: ONXX), a developer of cancer therapies, closed at ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


